Avinger Past Earnings Performance
Past criteria checks 0/6
Avinger has been growing earnings at an average annual rate of 6%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 0.8% per year.
Key information
6.0%
Earnings growth rate
87.5%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | 0.8% |
Return on equity | n/a |
Net Margin | -240.2% |
Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Avinger makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 23 | 8 | -19 | 14 | 5 |
30 Jun 23 | 8 | -22 | 14 | 5 |
31 Mar 23 | 8 | -22 | 14 | 5 |
31 Dec 22 | 8 | -27 | 14 | 4 |
30 Sep 22 | 9 | -28 | 15 | 5 |
30 Jun 22 | 9 | -29 | 15 | 5 |
31 Mar 22 | 9 | -27 | 16 | 5 |
31 Dec 21 | 10 | -22 | 16 | 6 |
30 Sep 21 | 10 | -21 | 16 | 6 |
30 Jun 21 | 10 | -21 | 15 | 6 |
31 Mar 21 | 9 | -22 | 14 | 6 |
31 Dec 20 | 9 | -23 | 14 | 6 |
30 Sep 20 | 9 | -23 | 15 | 6 |
30 Jun 20 | 9 | -23 | 15 | 6 |
31 Mar 20 | 10 | -24 | 17 | 6 |
31 Dec 19 | 9 | -23 | 17 | 6 |
30 Sep 19 | 9 | -24 | 17 | 6 |
30 Jun 19 | 8 | -25 | 18 | 6 |
31 Mar 19 | 8 | -26 | 18 | 6 |
31 Dec 18 | 8 | -36 | 18 | 6 |
30 Sep 18 | 8 | -39 | 18 | 6 |
30 Jun 18 | 8 | -43 | 19 | 7 |
31 Mar 18 | 8 | -49 | 20 | 9 |
31 Dec 17 | 10 | -49 | 25 | 11 |
30 Sep 17 | 13 | -52 | 29 | 13 |
30 Jun 17 | 16 | -55 | 34 | 15 |
31 Mar 17 | 18 | -55 | 37 | 15 |
31 Dec 16 | 19 | -56 | 40 | 16 |
30 Sep 16 | 17 | -56 | 40 | 15 |
30 Jun 16 | 15 | -56 | 38 | 16 |
31 Mar 16 | 13 | -53 | 35 | 16 |
31 Dec 15 | 11 | -50 | 29 | 16 |
30 Sep 15 | 11 | -44 | 25 | 15 |
30 Jun 15 | 11 | -40 | 23 | 13 |
31 Mar 15 | 11 | -37 | 21 | 12 |
31 Dec 14 | 11 | -32 | 19 | 11 |
30 Sep 14 | 12 | -32 | 18 | 12 |
30 Jun 14 | 12 | -33 | 20 | 12 |
31 Mar 14 | 12 | -37 | 23 | 14 |
31 Dec 13 | 13 | -40 | 26 | 16 |
31 Dec 12 | 9 | -34 | 23 | 15 |
Quality Earnings: VG20 is currently unprofitable.
Growing Profit Margin: VG20 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VG20 is unprofitable, but has reduced losses over the past 5 years at a rate of 6% per year.
Accelerating Growth: Unable to compare VG20's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VG20 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: VG20's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.